Your browser doesn't support javascript.
loading
Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis.
Alhusban, Ahmed; Al-Azayzih, Ahmad; Goc, Anna; Gao, Fei; Fagan, Susan C; Somanath, Payaningal R.
Afiliación
  • Alhusban A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Al-Azayzih A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Goc A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Gao F; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Fagan SC; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
  • Somanath PR; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Department
J Pharmacol Exp Ther ; 350(3): 635-45, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24990940

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Tetrazoles / Bencimidazoles / Inhibidores de la Angiogénesis / Ensayos Antitumor por Modelo de Xenoinjerto / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Año: 2014 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Tetrazoles / Bencimidazoles / Inhibidores de la Angiogénesis / Ensayos Antitumor por Modelo de Xenoinjerto / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Año: 2014 Tipo del documento: Article